K2Elevation
Overview
K2Elevation is a private investment firm established by Klaus Kleinfeld, focusing on technology and biotech sectors. The firm invests in and develops international enterprises, with a portfolio spanning the United States, Germany, and Austria. K2Elevation targets early-stage to late-stage companies, providing capital and strategic guidance to foster growth and innovation. The firm's investment philosophy emphasizes sustainable development and long-term value creation, leveraging Kleinfeld's extensive experience in leading global corporations and his network in the technology and biotech industries. K2Elevation's approach combines financial investment with active involvement in the strategic direction of its portfolio companies, aiming to drive transformative growth and market leadership. The firm's commitment to excellence is reflected in its selective investment criteria and its dedication to supporting visionary entrepreneurs and management teams.
Reach K2Elevation directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about K2Elevation
What sectors does K2Elevation invest in?
K2Elevation invests in Technology and Biotech, and is based in New York, United States. K2Elevation is listed as a private investment firm in the ConnectSafely investor database.
What stage does K2Elevation invest at?
K2Elevation backs companies at Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does K2Elevation invest in?
K2Elevation invests across United States, Germany and Austria.
Last updated · Source: ConnectSafely investor database
